Andersson, T.

Calculating measures of biological interaction

Andersson, T., Alfredsson, L., Källberg, H., Zdravkovic, S., & Ahlbom, A. (2005) · European Journal of Epidemiology

Statistical Methods in EpidemiologyAdvanced Causal Inference Techniques

Cited by 1,498

Smokeless tobacco (snus) is associated with an increased risk of type 2 diabetes: results from five pooled cohorts

Carlsson, S., Andersson, T., Araghi, M., Galanti, R., Lager, A., Lundberg, M., Nilsson, P., Norberg, M., Pedersen, N. L., Trolle‐Lagerros, Y., et al. (2017) · Journal of Internal Medicine

Smoking Behavior and CessationDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 68

Unprovoked seizures after traumatic brain injury: A population‐based case–control study

Mahler, B., Carlsson, S., Andersson, T., Adelöw, C., Ahlbom, A., & Tomson, T. (2015) · Epilepsia

Traumatic Brain Injury and Neurovascular DisturbancesEpilepsy research and treatment

Cited by 59

Use of snus and risk for cardiovascular disease: results from the Swedish Twin Registry

Hansson, J., Pedersen, N. L., Galanti, M. R., Andersson, T., Ahlbom, A., Hallqvist, J., & Magnusson, C. (2009) · Journal of Internal Medicine

Smoking Behavior and CessationCardiovascular Health and Risk Factors

Cited by 54

Use of Swedish smokeless tobacco (snus) and the risk of Type 2 diabetes and latent autoimmune diabetes of adulthood (LADA)

Rasouli, B., Andersson, T., Carlsson, P. ‐., Grill, V., Groop, L., Martinell, M., Midthjell, K., Storm, P., Tuomi, T., & Carlsson, S. (2017) · Diabetic Medicine

Smoking Behavior and CessationDiabetes and associated disorders

Cited by 24